ciprofloxacin has been researched along with Bladder Disorder, Neurogenic in 8 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of low-dose long-term treatment with ciprofloxacin in the prevention of recurrent urinary tract infections in patients with spinal cord lesions and neurogenic bladder dysfunction, a prospective, randomized, cross-over, placebo-controlled study was performed." | 5.07 | Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. ( Biering-Sørensen, F; Bruun, B; Høiby, N; Nordenbo, A; Rahm, V; Ravnborg, M, 1994) |
| "Multi-resistant nosocomial urinary tract infections occurring in thirty patients with neurogenic bladder dysfunction were treated with ciprofloxacin 100 mg twice daily Early bacteriological eradication was obtained in 48." | 5.06 | Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis. ( Baert, L; van Poppel, H, 1987) |
| "A study was performed in 25 men with spinal cord injuries undergoing intermittent catheterization whose urine had > or = 10(5) bacterial colonies/ml to determine efficacy of ciprofloxacin in eradicating susceptible organisms from urine, urethra, and perineum." | 3.70 | Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury. ( Brookings, ES; Canupp, KC; DeVivo, MJ; Waites, KB, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frazzini, V | 1 |
| Capasso, M | 1 |
| Onofrj, M | 1 |
| Khan, MH | 1 |
| Baldo, O | 1 |
| Koenig, P | 1 |
| Shaikh, N | 1 |
| Krasemann, C | 1 |
| Von Poppel, H | 1 |
| Wegge, M | 2 |
| Chysky, V | 2 |
| Biering-Sørensen, F | 1 |
| Høiby, N | 1 |
| Nordenbo, A | 1 |
| Ravnborg, M | 1 |
| Bruun, B | 1 |
| Rahm, V | 1 |
| Waites, KB | 1 |
| Canupp, KC | 1 |
| Brookings, ES | 1 |
| DeVivo, MJ | 1 |
| Van Poppel, H | 2 |
| Willemen, P | 1 |
| Kraseman, P | 1 |
| Baert, L | 2 |
| Boerema, JB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Treatment of Overactive Bladder: a Randomized Controlled Trial[NCT05519072] | Phase 4 | 140 participants (Anticipated) | Interventional | 2022-08-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for ciprofloxacin and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion.
Topics: Adult; Aged; Alanine Transaminase; Ciprofloxacin; Double-Blind Method; Feces; Female; Follow-Up Stud | 1994 |
Antibiotic cover of transurethral maneuvers with ciprofloxacin and susceptibility behavior of pathogens in patients with neurogenic bladder.
Topics: Bacteriuria; Ciprofloxacin; Cystoscopy; Double-Blind Method; Female; Humans; Male; Microbial Sensiti | 1990 |
Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis.
Topics: Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; M | 1987 |
5 other studies available for ciprofloxacin and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
An Uncommon Case of Hyperammonemic Encephalopathy.
Topics: Accidental Falls; Anti-Bacterial Agents; Brain Diseases; Ciprofloxacin; Dehydration; Electroencephal | 2019 |
Use of prophylactic antibiotics for intra-vesicle Botox® injection.
Topics: Acetylcholine Release Inhibitors; Administration, Intravesical; Anti-Bacterial Agents; Antibiotic Pr | 2017 |
Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.
Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Controlled Clinical Trials as Topic; Female; Huma | 1989 |
Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Humans; Male; M | 1999 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxa | 1986 |